Roivant Stock Analysis

ROIV
 Stock
  

USD 5.11  0.69  11.90%   

The latest price climb of Roivant Sciences created some momentum for sophisticated investors as it was traded today as low as 5.02 and as high as 5.25 per share. The company directors and management may have good odds in positioning the company resources to exploit market volatility in January. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.49. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Roivant Sciences partners.
Additionally, take a look at Your Equity Center.
  
The Roivant Sciences stock analysis report makes it easy to digest most publicly released information about Roivant Sciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Roivant Stock analysis module also helps to analyze the Roivant Sciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Roivant Stock Analysis Notes

About 39.0% of the company outstanding shares are owned by corporate insiders. The book value of Roivant Sciences was at this time reported as 1.65. The company recorded a loss per share of 4.52. Roivant Sciences had not issued any dividends in recent years. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people. To find out more about Roivant Sciences contact Matthew Gline at 44 2074 003 347 or learn more at https://roivant.com.

Roivant Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Roivant Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Roivant Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Roivant Sciences appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 55.29 M. Net Loss for the year was (845.26 M) with loss before overhead, payroll, taxes, and interest of (413.81 M).
Roivant Sciences currently holds about 1.94 B in cash with (677.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Roughly 39.0% of the company outstanding shares are owned by corporate insiders

Roivant Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 3.89 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Roivant Sciences's market, we take the total number of its shares issued and multiply it by Roivant Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (0.2487) % which means that it has lost $0.2487 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.6391) %, meaning that it created substantial loss on money invested by shareholders. Roivant Sciences management efficiency ratios could be used to measure how well roivant sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 2nd of December, Roivant Sciences holds the Semi Deviation of 3.66, risk adjusted performance of 0.299, and Coefficient Of Variation of 515.54. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Roivant Sciences, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Roivant Sciences, which can be compared to its competitors. Please check Roivant Sciences coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Roivant Sciences is priced some-what accurately, providing market reflects its current price of 5.11 per share. Given that Roivant Sciences has jensen alpha of 0.7296, we recommend you to check out Roivant Sciences's recent market performance to make sure the company can sustain itself at a future point.

Roivant Sciences Price Movement Analysis

The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Triangular Moving Average shows Roivant Sciences double smoothed mean price over a specified number of previous prices (i.e., averaged twice).
.

Roivant Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Roivant Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Roivant Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Roivant Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Roivant Sciences Technical and Predictive Indicators

Roivant Sciences Forecast Models

Roivant Sciences time-series forecasting models is one of many Roivant Sciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Roivant Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Roivant Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Roivant Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Roivant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Roivant Sciences. By using and applying Roivant Stock analysis, traders can create a robust methodology for identifying Roivant entry and exit points for their positions.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Roivant Sciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module
Additionally, take a look at Your Equity Center. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Roivant Sciences price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.9 B
Quarterly Revenue Growth YOY
(0.10) 
Return On Assets
(0.25) 
Return On Equity
(0.64) 
The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Roivant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.